Lampe M F, Suchland R J, Stamm W E
Department of Medicine, University of Washington, Seattle 98195.
Infect Immun. 1993 Jan;61(1):213-9. doi: 10.1128/iai.61.1.213-219.1993.
During studies in which we serotyped large numbers of Chlamydia trachomatis clinical isolates by using monoclonal antibodies, three novel serological variants (D-, D*, and I-) were identified. To determine the molecular basis for the altered monoclonal antibody reactions of these strains and other previously identified variants (Da, Ia, and L2a), we determined the nucleotide sequences of the variable domains in their major outer membrane protein genes. Da, D-, and D* variants differed by a single nucleotide and also an amino acid in the carboxy terminus of variable domain IV (VDIV) from the D serovar. The L2a variant also differed from L2 by a single amino acid but in VDII. Ia variants differed in VDI, III, and IV and I- variants differed in all four VDs from the I serovar. These studies demonstrate the potential for using major outer membrane protein VD sequencing as a highly sensitive typing method and further identify immunologically reactive major outer membrane protein epitopes.
在我们使用单克隆抗体对大量沙眼衣原体临床分离株进行血清分型的研究中,鉴定出了三种新的血清学变体(D-、D* 和 I-)。为了确定这些菌株以及其他先前鉴定的变体(Da、Ia 和 L2a)单克隆抗体反应改变的分子基础,我们测定了它们主要外膜蛋白基因可变区的核苷酸序列。Da、D- 和 D* 变体与 D 血清型相比,在可变区 IV(VDIV)的羧基末端有一个单核苷酸差异以及一个氨基酸差异。L2a 变体与 L2 相比也有一个氨基酸差异,但在 VDII 中。Ia 变体在 VDI、III 和 IV 中存在差异,而 I- 变体与 I 血清型相比在所有四个可变区中都存在差异。这些研究证明了使用主要外膜蛋白可变区测序作为一种高度灵敏的分型方法的潜力,并进一步鉴定了具有免疫反应性的主要外膜蛋白表位。